Maiken Keson-Brookes
Keine laufenden Positionen mehr
Vermögen: 224 974 $ am 31.03.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Caroline Loew | M | 54 | 1 Jahre | |
| Francis Cuss | M | 69 | 1 Jahre | |
| Adam Daniel Cutler | M | 50 | 1 Jahre | |
| Susan Altschuller | M | 42 | 1 Jahre | |
| Benjamin Hickey | M | 50 | 1 Jahre | |
| Scott Jackson | M | 59 | 1 Jahre | |
| James Jogerst | M | - | 3 Jahre | |
| Michael Dambach | M | 57 | 17 Jahre | |
| Vicki Goodman | M | 55 | 1 Jahre | |
| Marissa Hanify | F | - | 4 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Noubar Afeyan | M | 60 | 9 Jahre | |
| Stelios Papadopoulos | M | 75 | 15 Jahre | |
| Dannielle Appelhans | F | 41 | 2 Jahre | |
| Deborah Dunsire | M | 61 |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 3 Jahre |
| William Rastetter | M | 75 | 19 Jahre | |
| David Epstein | M | 62 | 5 Jahre | |
| Natalie Holles | F | 51 | 3 Jahre | |
| Thomas Wickham | M | - | 4 Jahre | |
| Eric S. Hoffman | M | 54 | 5 Jahre | |
| Lynne Sullivan | F | 58 | 10 Jahre | |
| Brian Posner | M | 62 | 14 Jahre | |
| Maria S. Gawryl | M | - |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 7 Jahre |
| Joanne M. Protano | F | 55 | 5 Jahre | |
| Gerhard Koenig | M | 63 |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 13 Jahre |
| Jose Carmona | M | 51 | 2 Jahre | |
| Nancy L. Leaming | F | 76 | 14 Jahre | |
| Samantha Truex | F | - | 8 Jahre | |
| Joseph Mara | M | 49 | - | |
| Anne Prener | M | 66 | 3 Jahre | |
| Alex Kuta | M | 64 | 6 Jahre | |
| Ben Harshbarger | M | 55 | 5 Jahre | |
| Elhan Webb | F | - | - | |
| Christina Coughlin | M | 54 | 1 Jahre | |
| Andrew Oh | M | 53 | 3 Jahre | |
| Marc Schegerin | M | 48 | 4 Jahre | |
| Andrea DiFabio | F | 55 | 11 Jahre | |
| Gisele Dion | F | 57 | 9 Jahre | |
| Timothy Piser | M | - |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 1 Jahre |
| Christopher Watt | M | 59 | 11 Jahre | |
| William Mccarthy | M | - | 1 Jahre | |
| Diego Cadavid | M | 58 | 8 Jahre | |
| Connie Matsui | F | 70 | 18 Jahre | |
| James Basta | M | 58 | - | |
| Christopher L. Carpenter | M | 68 | 3 Jahre | |
| Stephen Brannan | M | 67 |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 1 Jahre |
| Bethany Sensenig | F | 48 | 13 Jahre | |
| Susie Melody | F | - | 2 Jahre | |
| Mark Bodenrader | M | 51 | - | |
| Michael Pollock | M | - | 2 Jahre | |
| Joseph J. Kenny | M | - | 5 Jahre | |
| Kris Elverum | M | - | 2 Jahre | |
| Lisa Amaya Price | F | - | 8 Jahre | |
| Liisa I. Nogelo | F | 53 | 11 Jahre | |
| Abigail Bracha | M | - | 2 Jahre | |
| Greg Whitehead | M | - | 3 Jahre | |
| Michael W. Stevenson | M | - |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 2 Jahre |
| Ilise Lombardo | M | - |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | - |
| Karen Brennan | F | 68 |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 3 Jahre |
| Mark Meltz | M | 50 | 5 Jahre | |
| Theo Proukou | M | - | 5 Jahre | |
| Carlo Tanzi | M | - | 8 Jahre | |
| Esther Alegria | M | 66 | 10 Jahre | |
| Richard Francis | M | 55 | 8 Jahre | |
| William R. Rohn | M | 80 | 2 Jahre | |
| David Hallal | M | 57 | 2 Jahre | |
| Cecil B. Pickett | M | 78 | 3 Jahre | |
| Peter Kellogg | M | 67 | 4 Jahre | |
| Burt Adelman | M | 71 | 16 Jahre | |
| Mary L. Good | M | 93 | 10 Jahre | |
| Alan Belzer | M | 91 | 10 Jahre | |
| Raymond Pawlicki | M | 63 | 6 Jahre | |
| Michael MacLean | M | 58 | 4 Jahre | |
| Gregory Gorgas | M | 61 | 11 Jahre | |
| Philip Gotwals | M | 61 | 2 Jahre | |
| Arturo Molina | M | 65 | 4 Jahre | |
| Stephen Tulipano | M | 65 | 8 Jahre | |
| Faheem Hasnain | M | 65 | 4 Jahre | |
| Anne Cook | F | 62 | 13 Jahre | |
| Michael Gilman | M | 69 | 6 Jahre | |
| Robert L. de Jager | M | 82 | - | |
| Katherine J. Turner | M | 70 | 4 Jahre | |
| Scott Anthony Climes | M | 59 | 2 Jahre | |
| Allen Kamer | M | 53 | 3 Jahre | |
| Robert Dolski | M | 54 |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 3 Jahre |
| A. Sanders | F | 60 | 6 Jahre | |
| Christine Boisclair | F | - |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | - |
| Alfred Sandrock | M | 67 |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | - |
| Robert Gagnon | M | 49 | 7 Jahre | |
| Todd Shegog | M | 59 |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 2 Jahre |
| Eric W. Kimble | M | 58 | 5 Jahre | |
| John McCabe | M | 55 | 2 Jahre | |
| Bonne Adams | F | 47 | 2 Jahre | |
| Alessandra Cesano | M | 63 | 2 Jahre | |
| Akshay Vaishnaw | M | 61 | 7 Jahre | |
| Pratik Multani | M | 57 | 5 Jahre | |
| Daniel Char | M | 63 | 11 Jahre | |
| Dinah Sah | M | 63 | 6 Jahre | |
| Melissa Morandi | F | 59 | 2 Jahre | |
| Timothy Kelly | M | 55 | 7 Jahre | |
| Bryan Gillis | M | - | 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 92 | 92,00% |
| Niederlande | 1 | 1,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Maiken Keson-Brookes
- Persönliches Netzwerk
